RIP2 regulates growth and differentiation of normal myoblasts and of rhabdomyosarcoma cells

European Journal of Cell Biology

Volumn 87, Issue 3, 2008, Pages 163-172

  Ehlers, Svenja ^a   Mueck, Tobias ^a   Adams, Stephanie ^a   Landuzzi, Lorena ^b   Lollini, Pier Luigi ^c   Munz, Barbara ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Rhabdomyosarcoma; RIP proteins; Skeletal muscle

Indexed keywords

BINDING PROTEIN; RECEPTOR INTERACTING PROTEIN 1; RECEPTOR INTERACTING PROTEIN 2; RECEPTOR INTERACTING PROTEIN 3; RECEPTOR INTERACTING PROTEIN 4; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RHABDOMYOSARCOMA; RNA ISOLATION; WESTERN BLOTTING;

EID: 39149131697     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcb.2007.08.003     Document Type: Article

References (20)

1. Astolfi A., De Giovanni C., Landuzzi L., Nicoletti G., Ricci C., Croci S., Scopece L., Nanni P., and Lollini P.-L. Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells. Gene 274 (2001) 139-149
2. Bähr C., Rohwer A., Stempka L., Rincke G., Marks F., and Gschwendt M. DIK, a novel protein kinase that interacts with protein kinase Cδ. J. Biol. Chem. 275 (2000) 36350-36357
3. Chen L., Haider K., Ponda M., Cariappa A., Rowitch D., and Pillai S. Protein kinase C-associated kinase (PKK) is a novel membrane-associated ankyrin repeat-containing protein kinase. J. Biol. Chem. 276 (2001) 21737-21744
4. Croci S., Landuzzi L., Astolfi A., Nicoletti G., Rosolen A., Sartori F., Follo M.Y., Oliver N., De Giovanni C., Nanni P., and Lollini P.-L. Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells. Cancer Res. 64 (2004) 1730-1736
5. Guttridge D.C., Albanese C., Reuther J.Y., Pestell R.G., and Baldwin Jr. A.S. NF-kappa B controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell Biol. 19 (1999) 5785-5799
6. Holland P., Willis C., Kanaly S., Glaccum M., Warren A., Charrier K., Murison J., Derry J., Virca G., Bird T., and Peschon J. RIP4 is an ankyrin repeat-containing kinase essential for keratinocyte differentiation. Curr. Biol. 12 (2002) 1424-1428
7. Inohara N., del Peso L., Koseki T., Chen S., and Nunez G. RICK, a novel protein kinase containing a caspase recruitment domain interacts with CLARP and regulates CD95-mediated apoptosis. J. Biol. Chem. 273 (1998) 12296-12300
8. Lollini P.-L., De Giovanni C., Landuzzi L., Nicoletti G., Scotlandi K., and Nanni P. Reduced metastatic ability of in vitro differentiated human rhabdomyosarcoma cells. Invasion Metastasis 11 (1991) 118-124
9. McCarthy J.V., Ni J., and Dixit V.M. RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase. J. Biol. Chem. 273 (1998) 16968-16975
10. Meylan E., and Tschopp J. The RIP kinases: crucial integrators of cellular stress. Trends Biochem. Sci. 30 (2005) 151-159
11. Meylan E., Martinon F., Thome M., Gschwendt M., and Tschopp J. RIP4 (DIK/PKK), a novel member of the RIP kinase family, activates NF-kappa B and is processed during apoptosis. EMBO Rep. 3 (2002) 1201-1208
12. Munz B., Hildt E., Springer M.L., and Blau H.M. RIP2, a checkpoint in myogenic differentiation. Mol. Cell Biol. 22 (2002) 5879-5886
13. Navas T.A., Baldwin D.T., and Stewart T.A. RIP2 is a Raf1-activated mitogen-activated protein kinase kinase. J. Biol. Chem. 274 (1999) 33684-33690
14. Padzernik N.J., Donner D.B., Goebl M.G., and Harrington M.A. Mouse receptor interacting protein 3 does not contain a caspase-recruiting or a death domain but induces apoptosis and activates NF-kappaB. Mol. Cell Biol. 19 (1999) 6500-6508
15. Stanger B.Z., Leder P., Lee T.H., Kim E., and Seed B. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81 (1995) 513-523
16. Sun X., Lee J., Navas T., Baldwin D.T., Stewart T.A., and Dixit V.M. RIP3, a novel apoptosis-inducing kinase. J. Biol. Chem. 274 (1999) 16871-16875
17. Thome M., Hofmann K., Burns K., Martinon F., Bodmer J.L., Mattmann C., and Tschopp J. Identification of CARDIAK, a RIP-like kinase that associates with caspase-1. Curr. Biol. 8 (1998) 885-888
18. Xia S.J., Pressey J.G., and Barr F.G. Molecular pathogenesis of rhabdomyosarcoma. Cancer Biol. Ther. 1 (2002) 97-104
19. Yu P.W., Huang B.C., Shen M., Quast J., Chan E., Xu X., Nolan G.P., Payan D.G., and Luo Y. Identification of RIP3, a RIP-like kinase that activates apoptosis and NF-kappaB. Curr. Biol. 9 (1999) 539-542
20. Zha J., Zhou Q., Xu L.G., Chen D., Li L., Zhai Z., and Shu H.B. RIP5 is a RIP-homologous inducer of cell death. Biochem. Biophys. Res. Commun. 319 (2004) 298-303